IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,243,914 | -94.6% | 57,039 | -96.7% | 0.00% | -95.2% |
| Q1 2023 | $41,891,337 | +14.4% | 1,721,798 | +0.6% | 0.02% | +10.5% |
| Q4 2022 | $36,630,433 | +19.3% | 1,710,903 | -0.0% | 0.02% | +11.8% |
| Q3 2022 | $30,703,000 | +159.8% | 1,711,434 | +39.3% | 0.02% | +183.3% |
| Q2 2022 | $11,818,000 | -42.8% | 1,228,500 | +0.1% | 0.01% | -25.0% |
| Q1 2022 | $20,664,000 | +0.5% | 1,227,768 | -0.1% | 0.01% | +14.3% |
| Q4 2021 | $20,558,000 | +1081.5% | 1,229,593 | +1047.7% | 0.01% | +600.0% |
| Q3 2021 | $1,740,000 | – | 107,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
| Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
| Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
| COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
| Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
| ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
| Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
| Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
| Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
| Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |